lapatinib,trastuzumab
roche,novartis
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'altto']
#icymi #esmo22 in case-controlled cohort of pts receiving adj trastuzumab in #altto study, rna seq. identified 4 tumor subgroups associated w prognosis. luminal &amp; immune-enriched subgroups have excellent prognosis-could be evaluated for de-escalation approaches 
Breast International Group - Facilitating and accelerating breast cancer research internationally